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We present a review of the outcome of routine serological screening for syphilis among pregnant women who received antenatal care at the University of Nigeria teaching hospital in Enugu, eastern Nigeria.
Methods
This was a retrospective review of results of serological tests for syphilis for pregnant women during the period 1 January 1991 to 31 December 1997.
Results
These are presented in table 1 .
Owing to the unavailability of the Treponema pallidum haemagglutination assay (TPHA) reagents at certain times and the inability of some women to aVord the cost of screening, only 30 of the 148 VDRL reactive serum samples were subjected to TPHA, with three being positive. Thus, 10% of the VDRL reactive sera were also TPHA reactive. This TPHA/VDRL ratio is similar to the 11.6% observed in an earlier study in our centre. 2 Should this ratio be projected for other VDRL reactive sera not subjected to the TPHA test, a total of 15 TPHA reactive sera may be obtained. This will give a VDRL and TPHA reactivity of 0.13%.
Discussion
This study reveals a low prevalence rate of syphilis of 0.13% based on VDRL and TPHA reactivity and is comparable with the 0.15% observed in Amsterdam between 1985 and 1989 . 3 This indicates a threefold decline from the 0.35% reported from our institution for the period 1979 to 1984. A similar trend has also been observed in Ibadan, a city in western Nigeria. 4 5 There the seropositivity rate declined from 2.3% between 1976 and 1985 to 1.55% in the succeeding 10 years. However, these results were based on VDRL only as TPHA was not available. Thus, the rates could have been lower. In our institution, VDRL seroreactivity has similarly declined from 3.06% to 1.3%. 2 The downward trend in seroreactivity in Enugu could be due to greater awareness of pregnant women, created during antenatal classes, about the features and complications of syphilis as well as the availability of cure with prompt medication.
The high proportion of booked women not screened (20.6%) gives concern since the impact of syphilis on pregnancy may be grave but preventable. Better education of the women by both doctors and nursing staV, and the introduction of the proposed national health insurance scheme, should lead to an increase in the screening rate.
Although the prevalence rate is low we support the continued screening of pregnant women since this will help eliminate the adverse eVects of untreated syphilis. Finally, since the TPHA reagent may not always be available in a developing country such as Nigeria, coupled with the inability of some women to aVord the cost of both VDRL and TPHA tests, we recommend the treatment of all women reactive to the VDRL test. Such a policy should ensure that no cases are missed especially as the drugs used are considered safe in pregnancy. It may also result in a further decline in VDRL and TPHA seroreactivity. In addition, concurrent treatment of partners should be considered. 
Methods
Ethical clearance was obtained. A stratified cluster sample of school attending girls was taken from the three senior classes and the number of girls in each year was proportional to the total number of girls in that year over the five schools. Consent was obtained from parents and individual girls. Questions on sexual behaviour were asked by trained peer interviewers. At the clinics (held in school or a nearby health centre) all girls were given a general examination and, if sexually active, samples were taken for a vaginal wet mount for Trichomonas vaginalis, culture of Candida albicans, and Neisseria gonorrhoeae, antigen detection of Chlamydia trachomatis, and urinalysis (leucocyte esterase test). Blood was taken to test for treponemal infections. Samples were handled within 4-6 hours of collection as previously described. 1 The sensitivity, specificity, and positive predictive value of vaginal discharge for presence of an STI was calculated, and logistic regression was used to determine the association of social factors and risk of STI.
Results
A total of 1066 unmarried girls were recruited. Their mean age was 16.8 years (SD 1.3 years) and 51.1% (545) were sexually experienced. Prevalence of STIs was as follows: gonorrhoea, 2.1%; chlamydia, 2.1%; syphilis, 1.0%; trichomoniasis, 9.1%. In all, 13.8% had any STI and 11.1% had symptomatic candidosis. Table 1 shows that after adjustment for confounding factors, having a partner >25 years (p = 0.00) and having a partner whose occupation was "other" (that is, a miscellaneous category: p=0.03) was associated with being positive for any STI. Non-sexually experienced girls were almost as likely to report any discharge (43.4%) as the sexually experienced (53.6%). For the latter, the sensitivity of "any" discharge was 87.5% for gonorrhoea, 62.9% for trichomoniasis, and 50.0% for chlamydia. Specificity was 46.3%, 46.6%, and 45.7% respectively. Positive predictive values for all types of discharge were generally poor. As for clinical signs of cervicitis: 6.1% of girls with ectropion, hyperaemia, or purulent discharge were positive for either chlamydia or gonorrhoea. Endocervical polymorph counts were raised in girls both with and without infection (mean count 16.8 and 8.9 respectively). The leucocyte esterase test was positive (any level) for 22.6% of girls with an STI compared with 3.4% of girls with no reproductive tract infection.
Comment
STIs were not detected as frequently as had been expected and would not have been accurately determined on the basis of signs, symptoms, or non-specific tests. Low STI prevalence may have been due to limited sexual involvement and choice of a low risk partner (table 1)-behaviours which vary between populations. 2 3 Neither reported condom use nor previous antibiotic use accounted for the low prevalence. Vaginal infections predominated and, though associated with less serious morbidity than cervical infections, their treatment can form an entry point for advising girls on sexual health issues. Adolescent health programmes should not assume a high STI risk and need to use the clinical management algorithms recommended by the World Health Organisation cautiously, as these tend to overdiagnose cervical infections. 4 Baseline information on STI prevalence is required to tailor them appropriately. 5 This study was funded by the Department for International Development which accepts no responsibility for the views expressed. Many people in Nigeria contributed to this study; we thank them all. 
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Introduction
Mumbai (formerly Bombay), situated on the west coast of India, is the industrial, financial, and commercial capital of India. In the past two decades, urbanisation and industrialisation have led to rapid population growth and migration. Almost half of the population lives in slums. Thirty three gonococcal isolates were taken from women attending tertiary level health centres and the STD clinic in Mumbai city. Quinolones have been suggested as a single dose treatment for uncomplicated gonorrhoea. National AIDS Control Organisation (India) has recommended a single 800 mg dose of norfloxacin, which has now been replaced with 500 mg ciprofloxacin. 1 Resistance to sulphonamides, penicillin, and tetracycline in Neisseria gonorrhoeae, has developed within years of their introduction. In 1993, fluoroquinolones and third generation cephalosporins have been recommended for the primary treatment of uncomplicated gonorrhoea. 2 Ofloxacin has been used extensively in the treatment of urethritis in the South East Asian region. There have been sporadic reports of quinolone resistance among gonococci. 
Methods
Thirty three N gonorrhoeae isolates from women attending tertiary level health centres and STD clinic attenders were tested. Agar dilution and disc diVusion susceptibility testing was performed and interpreted according to the NCCLS guidelines. 4 Lactamase production was performed by the iodometric method. Plasmid analysis was performed by the method of Birnboim and Doly.
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Results
Of the five ciprofloxacin resistant isolates, two were penicillinase producers (PPNG), one was susceptible, and two exhibited reduced susceptibility to penicillin. No plasmid mediated high level tetracycline resistance was observed in the isolates studied. Fifteen of the 16 penicillin resistant isolates were PPNG.
All the isolates were susceptible to spectinomycin. Minimum inhibitory concentrations (MICs) of the isolates to the five antimicrobials tested are shown in table 1.
Ten (71.4%) isolates had the 4.4 MDa ("Asian" type) plasmid whereas four (28.6%) possessed the 3.2 MDa plasmid. Distribution of the conjugative and cryptic plasmid among the PPNG isolates is shown in table 2.
Discussion
Over the years the prevalence of PPNG has increased from 2.3% in 1983 to 17.3% in 1988. 6 7 The occurrence of fluoroquinolone resistance has been recognised increasingly and is considered to be the principal threat to the future use of this class of antibiotics. 8 The 4.4 MDa plasmid was the most prevalent among the isolates studied. Similar results were reported in studies elsewhere. 6 9 The decrease in susceptibility and emergence of quinolone resistance could be a result of selective pressure following use of quinolones as the mainstay in treatment of uncomplicated gonorrhoea. The presence of ciprofloxacin resistance indicates the need for continuous monitoring of quinolone susceptibility.
We wish to acknowledge the dean of the institute and health authorities of Brihanmumbai Mahanagar Palika (BMC) for permitting us to use the clinical material. DiVerence in seroprevalence of herpes simplex virus type 2 infection among antenatal women in Hong Kong and southern China
Demographic data
Seroprevalence of herpes simplex virus type 2 (HSV-2) has been regarded as an indicator of the sexual behaviour of a population. 1 Rising trends have been detected over the years. 2 We undertook a Hong Kong based seroprevalence study of HSV in various population groups, including the general population, sexually transmitted disease (STD) clinic attendees, and pregnant women. Pregnant women originating from southern mainland China were identified by their registration at antenatal clinics in Hong Kong using travel permits in lieu of Hong Kong identity cards.
Methods
Our laboratory provides diagnostic and public health virology services in Hong Kong. Consecutive serum samples submitted to our laboratory in late 1995 from the above population groups were retrieved for the current study. The specimens were intended for diagnostic or screening purposes unrelated to HSV infection and were kept at −20°C. All sera were tested for type specific HSV antibodies in an unlinked anonymous manner using the western blot method, which we had previously published. 3 Serum samples known to be positive and negative for HSV-1 and 2 antibodies were included as controls in each test run. Statistical significance was determined using the 2 test.
Results
Results are shown in table 1.
Discussion
The HSV-2 seroprevalence rates in Hong Kong for various population groups are within the ranges reported worldwide. 4 It isinteresting to note that the HSV-2 seroprevalence rate from antenatal women resid ing in mainland China just across the border is much lower than that in Hong Kong (p <0.05). To further study the situation, we tested archived sera (stored at −20°C) from the general population in Hong Kong in 1977. The HSV-2 seroprevalence rate among women over 25 years of age was 5/74 (6.8%), p <0.05 when compared with a demographically similar group in 1995.
From the above observations, it is evident that from 1977 to 1995, the rate of HSV-2 infections in Hong Kong has significantly increased. Additionally, mainland China has a much lower HSV-2 seroprevalence rate than Hong Kong among pregnant women. With the return of the sovereignty of Hong Kong to China, the relation between these two neighbouring localities will undoubtedly become increasingly intimate. Travel across the border has increased in terms of business, family visits, and tourism. Together with the rapid socioeconomic development of mainland China, it is anticipated that the number of STDs will increase. It is thus crucial for public health authorities to recognise this potential problem early and to formulate appropriate control strategies for STDs, not only for HSV-2, but also for other infections, especially HIV, which has no cure so far. Measures will mainly take the forms of educating the public about STDs and behavioural modification programmes such as promotion of condom use. Results from the current study will serve as baseline data for monitoring the implementation of STD prevention programmes. Secular trends should be determined by serial seroepidemiological studies. Other population groups should also be tested so that control programmes may be rationally targeted at high risk groups. 
